Page last updated: 2024-11-04

tegafur and Epstein-Barr Virus Infections

tegafur has been researched along with Epstein-Barr Virus Infections in 2 studies

Epstein-Barr Virus Infections: Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yanai, H1
Yahara, N1
Furuya, T1
Hayashi, H1
Murakami, T1
Shimokawa, Y1
Sugihara, S1
Seya, T1
Tanaka, N1
Yokoi, K1
Ishikawa, N1
Horiba, K1
Kanazawa, Y1
Yamada, T1
Koizumi, M1
Shinji, S1
Okazaki, H1
Ohaki, Y1
Ishiwata, T1
Naito, Z1
Tajiri, T1

Other Studies

2 other studies available for tegafur and Epstein-Barr Virus Infections

ArticleYear
Long-Term Survival of Patient with Epstein-Barr Virus-Positive Gastric Cancer Treated with Chemotherapy: Case Report.
    Journal of gastrointestinal cancer, 2016, Volume: 47, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin;

2016
Complete response of a patient with advanced gastric cancer, showing Epstein-Barr virus infection, to preoperative chemotherapy with S-1 and cisplatin.
    International journal of clinical oncology, 2007, Volume: 12, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Epstein-Barr Vir

2007